Real-world efficacy and safety of ocrelizumab in Belgium in PPMS patients according to the prevailing reimbursement criteria Last updated: 2023-02-03 03:36
A Prospective Observational Registry to describe the disease course and outcomes of Idiopathic Pulmonary Fibrosis patients in a real-world clinical setting Last updated: 2023-02-03 03:36